Clinical Trial

18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors

Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the potential usefulness of 18F-FAPI-04 positron emission tomography/computed tomography (PET/CT) and positron emission tomography/magnetic resonance imaging （PET/MR）for the diagnosis of primary and metastatic lesions, detection of recurrence or assessment of pathologic response in various types of cancer.
Trial Details
NCT Number NCT06557590
Lead Sponsor Hunan Cancer Hospital
Conditions Cancer, FAP
Enrollment 500 participants
Start Date 2024-01-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-16